Cargando…

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study

BACKGROUND: Hypertension is highly prevalent during chronic kidney disease (CKD) and, in turn, worsens CKD prognosis. We aimed to describe the determinants of uncontrolled and resistant hypertension during CKD. METHODS AND RESULTS: We analyzed baseline data from patients with CKD stage 1 to 5 (Nephr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidal‐Petiot, Emmanuelle, Metzger, Marie, Faucon, Anne‐Laure, Boffa, Jean‐Jacques, Haymann, Jean‐Philippe, Thervet, Eric, Houillier, Pascal, Geri, Guillaume, Stengel, Bénédicte, Vrtovsnik, François, Flamant, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404875/
https://www.ncbi.nlm.nih.gov/pubmed/30371309
http://dx.doi.org/10.1161/JAHA.118.010278
_version_ 1783400969142272000
author Vidal‐Petiot, Emmanuelle
Metzger, Marie
Faucon, Anne‐Laure
Boffa, Jean‐Jacques
Haymann, Jean‐Philippe
Thervet, Eric
Houillier, Pascal
Geri, Guillaume
Stengel, Bénédicte
Vrtovsnik, François
Flamant, Martin
author_facet Vidal‐Petiot, Emmanuelle
Metzger, Marie
Faucon, Anne‐Laure
Boffa, Jean‐Jacques
Haymann, Jean‐Philippe
Thervet, Eric
Houillier, Pascal
Geri, Guillaume
Stengel, Bénédicte
Vrtovsnik, François
Flamant, Martin
author_sort Vidal‐Petiot, Emmanuelle
collection PubMed
description BACKGROUND: Hypertension is highly prevalent during chronic kidney disease (CKD) and, in turn, worsens CKD prognosis. We aimed to describe the determinants of uncontrolled and resistant hypertension during CKD. METHODS AND RESULTS: We analyzed baseline data from patients with CKD stage 1 to 5 (NephroTest cohort) who underwent thorough renal explorations, including measurements of glomerular filtration rate (clearance of (51)Cr‐EDTA) and of extracellular water (volume of distribution of the tracer). Hypertension was defined as blood pressure (BP; average of 3 office measurements) ≥140/90 mm Hg or the use of antihypertensive drugs. In 2015 patients (mean age, 58.7±15.3 years; 67% men; mean glomerular filtration rate, 42±15 mL/min per 1.73 m(2)), prevalence of hypertension was 88%. Among hypertensive patients, 44% and 32% had uncontrolled (≥140/90 mm Hg) and resistant (uncontrolled BP despite 3 drugs, including a diuretic, or ≥4 drugs, including a diuretic, regardless of BP level) hypertension, respectively. In multivariable analysis, extracellular water, older age, higher albuminuria, diabetic nephropathy, and the absence of aldosterone blockers were independently associated with uncontrolled BP. Extracellular water, older age, lower glomerular filtration rate, higher albuminuria and body mass index, male sex, African origin, diabetes mellitus, and diabetic and glomerular nephropathies were associated with resistant hypertension. CONCLUSIONS: In this large population of patients with CKD, a lower glomerular filtration rate, a higher body mass index, diabetic status, and African origin were associated with hypertension severity but not with BP control. Higher extracellular water, older age, and higher albuminuria were independent determinants of both resistant and uncontrolled hypertension during CKD. Our results advocate for the large use of diuretics in this population.
format Online
Article
Text
id pubmed-6404875
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64048752019-03-19 Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study Vidal‐Petiot, Emmanuelle Metzger, Marie Faucon, Anne‐Laure Boffa, Jean‐Jacques Haymann, Jean‐Philippe Thervet, Eric Houillier, Pascal Geri, Guillaume Stengel, Bénédicte Vrtovsnik, François Flamant, Martin J Am Heart Assoc Original Research BACKGROUND: Hypertension is highly prevalent during chronic kidney disease (CKD) and, in turn, worsens CKD prognosis. We aimed to describe the determinants of uncontrolled and resistant hypertension during CKD. METHODS AND RESULTS: We analyzed baseline data from patients with CKD stage 1 to 5 (NephroTest cohort) who underwent thorough renal explorations, including measurements of glomerular filtration rate (clearance of (51)Cr‐EDTA) and of extracellular water (volume of distribution of the tracer). Hypertension was defined as blood pressure (BP; average of 3 office measurements) ≥140/90 mm Hg or the use of antihypertensive drugs. In 2015 patients (mean age, 58.7±15.3 years; 67% men; mean glomerular filtration rate, 42±15 mL/min per 1.73 m(2)), prevalence of hypertension was 88%. Among hypertensive patients, 44% and 32% had uncontrolled (≥140/90 mm Hg) and resistant (uncontrolled BP despite 3 drugs, including a diuretic, or ≥4 drugs, including a diuretic, regardless of BP level) hypertension, respectively. In multivariable analysis, extracellular water, older age, higher albuminuria, diabetic nephropathy, and the absence of aldosterone blockers were independently associated with uncontrolled BP. Extracellular water, older age, lower glomerular filtration rate, higher albuminuria and body mass index, male sex, African origin, diabetes mellitus, and diabetic and glomerular nephropathies were associated with resistant hypertension. CONCLUSIONS: In this large population of patients with CKD, a lower glomerular filtration rate, a higher body mass index, diabetic status, and African origin were associated with hypertension severity but not with BP control. Higher extracellular water, older age, and higher albuminuria were independent determinants of both resistant and uncontrolled hypertension during CKD. Our results advocate for the large use of diuretics in this population. John Wiley and Sons Inc. 2018-09-19 /pmc/articles/PMC6404875/ /pubmed/30371309 http://dx.doi.org/10.1161/JAHA.118.010278 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Vidal‐Petiot, Emmanuelle
Metzger, Marie
Faucon, Anne‐Laure
Boffa, Jean‐Jacques
Haymann, Jean‐Philippe
Thervet, Eric
Houillier, Pascal
Geri, Guillaume
Stengel, Bénédicte
Vrtovsnik, François
Flamant, Martin
Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title_full Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title_fullStr Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title_full_unstemmed Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title_short Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
title_sort extracellular fluid volume is an independent determinant of uncontrolled and resistant hypertension in chronic kidney disease: a nephrotest cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404875/
https://www.ncbi.nlm.nih.gov/pubmed/30371309
http://dx.doi.org/10.1161/JAHA.118.010278
work_keys_str_mv AT vidalpetiotemmanuelle extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT metzgermarie extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT fauconannelaure extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT boffajeanjacques extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT haymannjeanphilippe extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT therveteric extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT houillierpascal extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT geriguillaume extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT stengelbenedicte extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT vrtovsnikfrancois extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT flamantmartin extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy
AT extracellularfluidvolumeisanindependentdeterminantofuncontrolledandresistanthypertensioninchronickidneydiseaseanephrotestcohortstudy